The pharmacokinetic models proposed for atracurium or cisatracurium are based on the assumption that spontaneous degradation via Hofmann elimination proceeds in vivo at the same rate as measured in vitro at pH 7.4 and 37ЊC. As different degradation rates have been reported for all 10 stereoisomers of atracurium measured together for each of its three isomeric groups, and for the single isomer cisatracurium, we studied if the rate is dependent on factors other than pH and temperature. In vitro degradation of atracurium and cisatracurium was studied at 37ЊC and pH 7.4 in nine incubating solutions containing one of three buffer systems (phosphate, HEPES or Tris) and additives (sodium chloride, potassium sulphate or glucose). Concentrations of atracurium, cisatracurium and laudanosine were measured after incubation for up to 240 min using an HPLC method. Degradation of atracurium proceeded monoexponentially. The rate was slower in the presence of sodium chloride, potassium sulphate, and in a lower concentration of the phosphate buffer. Glucose enhanced the degradation. At the same total buffer concentration (50 mmol were similar to those of atracurium. We conclude that, at constant pH and temperature, the degradation rate of atracurium was dependent on the total concentration of the base in the incubating solution. (Br. J. Anaesth. 1998; 81: 409-414).
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Summary
The pharmacokinetic models proposed for atracurium or cisatracurium are based on the assumption that spontaneous degradation via Hofmann elimination proceeds in vivo at the same rate as measured in vitro at pH 7.4 and 37ЊC. As different degradation rates have been reported for all 10 stereoisomers of atracurium measured together for each of its three isomeric groups, and for the single isomer cisatracurium, we studied if the rate is dependent on factors other than pH and temperature. In vitro degradation of atracurium and cisatracurium was studied at 37ЊC and pH 7.4 in nine incubating solutions containing one of three buffer systems (phosphate, HEPES or Tris) and additives (sodium chloride, potassium sulphate or glucose). Concentrations of atracurium, cisatracurium and laudanosine were measured after incubation for up to 240 min using an HPLC method. Degradation of atracurium proceeded monoexponentially. The rate was slower in the presence of sodium chloride, potassium sulphate, and in a lower concentration of the phosphate buffer. Glucose enhanced the degradation. At the same total buffer concentration (50 mmol litre 91 ), degradation was fastest in the phosphate, intermediate in the HEPES and slowest in the Tris buffer. Degradation rates of cisatracurium in sodium phosphate 50 mmol litre 91 and Sörensen (Na-K phosphate) buffer 66.7 mmol litre 91 were similar to those of atracurium. We conclude that, at constant pH and temperature, the degradation rate of atracurium was dependent on the total concentration of the base in the incubating solution. (Br. J. Anaesth. 1998; 81: 409-414).
Keywords: neuromuscular block, atracurium; neuromuscular block, cisatracurium; pharmacokinetics, atracurium; pharmacokinetics, cisatracurium Inhibition of neuromuscular transmission by atracurium is caused by the presence of a quaternary nitrogen at each of the two bulky ends that are linked by an aliphatic chain. In chemical terms, atracurium is characterized by two reverse esters in the chain and four chiral centres at each bulky end. The reverse esters facilitate the fission of the chain via an elimination reaction, commonly known as Hofmann elimination. Laudanosine and a quaternary acrylate are the degradation products ( fig. 1) . The esters may also be hydrolysed by carboxyl esterase yielding a quaternary acid and a quaternary alcohol. As the elimination reaction requires a reversed ester two carbon atoms distant from the quaternary nitrogen and the condition is satisfied in the quaternary acrylate metabolite, this product may undergo a further elimination reaction to yield a second molecule of laudanosine and a bis-acrylate. The quaternary acid does not undergo the elimination reaction.
Because of the presence of four chiral centres, the atracurium molecule is present in 10 steric configurations. The 10 isomers may be arranged in three isomeric groups labelled cis-cis, cis-trans or trans-trans. Recently, the 1R-cis, 1'R-cis isomer was isolated and named cisatracurium. The cis-cis isomeric group constitutes approximately 57.8%, 1 and cisatracurium approximately 14%, 2 of the atracurium mixture. Degradation of atracurium in vitro at pH 7.4 and 37ЊC was estimated previously for all 10 stereoisomers together, 3 for each of the three isomeric groups separately, 1 and for the single stereoisomer cisatracurium. 2 The reported degradation rates differed. As the degradation rate of atracurium is important for understanding its fate in the human body and plays a key role in pharmacokinetic modelling, we examined systematically the degradation rates of atracurium and cisatracurium in vitro for different clearly defined incubation solutions. In each instance, pH and temperature were maintained constant at 7.4 and 37ЊC, respectively. . The following concentration gradient was used: 0-4 min, 100% A; 4-6 min, from 100% A to 100% B; 6-10 min, 100% B; 10-12 min, from 100% B to 100% A; 12-14 min, 100% A. Flow rates were 1.5 ml min 91 for A and 2.5 ml min 91 for B. The fluorometric detector (Shimadzu Corp., Kyoto, Japan) was set to 280 nm for excitation and 320 nm for emission. The limit of detection was 5 ng ml 91 (4 nmol litre
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91
) for atracurium or cisatracurium and 2 ng ml 91 (5.6 nmol litre 91 ) for laudanosine.
DATA ANALYSIS AND THE MATHEMATICAL MODEL
A kinetic model was formulated (scheme 1) to represent degradation of the parent compounds (atracurium or cisatracurium) via the elimination reaction. The model describes sequential formation of two laudanosine molecules (Ldn 1 and Ldn 2 ) from one molecule of atracurium or cisatracurium, the first being formed during the degradation of the parent drug (Atr): tion rate of atracurium and rate of formation of the first molecule of laudanosine (Ldn 1 ). Quaternary monoacrylate (QMA), formed concurrently with the first molecule of laudanosine, was postulated to undergo further elimination yielding the second molecule of laudanosine and bis-acrylate (BA). The corresponding rate constant was designated k 2 . The model was fitted to time-dependent, measured concentrations of atracurium or cisatracurium and to the sum of both laudanosine molecules (Ldn total ) in each experiment; the respective half-lives were calculated as T 1/2 :ln(2)/k. Equations describing these processes are presented in the appendix. The mean values for the rate constants for each incubating solution were calculated with the corresponding standard deviations; the goodness of fit was defined by the coefficient of determination. The coefficients of determination are presented as the range of the worst and best fits.
Results
Results obtained by incubating atracurium or cisatracurium at pH 7.4 and 37ЊC are presented in Accordingly, the formation rates of laudanosine varied; under all incubating conditions the total concentrations of laudanosine at the end of the incubations were compatible with the postulate that one molecule of atracurium degrades into two molecules of laudanosine. With the exception of the incubating solutions F and I, the formation of the second molecule of laudanosine proceeded at a slower rate than the formation of the first molecule (table 2). For each incubating solution, the coefficients of determination for the best and worst fits are also presented in Degradation of cisatracurium was measured in the incubating solutions A and E (table 2). The rates of degradation were comparable under these conditions. Moreover, the estimated rates for the degradation of cisatracurium were similar to those for atracurium incubated under identical conditions.
Discussion
The results of incubations in different solutions, but under constant pH (7.4) and temperature (37ЊC), demonstrated markedly different rates of degradation of atracurium. In comparison with degradation in plain sodium phosphate buffer 50 mmol litre 91 , addition of sodium chloride or potassium sulphate markedly retarded the degradation while the addition of glucose increased the rate. The rates were also different in three buffers, at concentrations of 50 mmol litre
91
. In phosphate buffers, solutions A and E, degradation of cisatracurium was comparable with that of atracurium. Under all incubating conditions the rates of degradation of atracurium or cisatracurium showed monoexponential decay and formation of two molecules of laudanosine from one molecule of atracurium or cisatracurium.
Would separate measurements of each of the 10 isomers yield results different from those we obtained by measuring all as atracurium? We are convinced that such an analytical approach would not have altered the results. First, the degradation rates of atracurium and of the single stereoisomer cisatracurium demonstrated no systematic differences. Second, the results by Tsui, Graham and Torda 1 also support the notion that the three isomeric groups of atracurium decay at the same rate. Given the composition of 57.8% cis-cis, 36.5% cistrans and 5.7% of the trans-trans isomeric groups, the authors reported corresponding degradation halflives of 57.1, 59.7 and 66.4 min; hence decay of the trans-trans isomeric group was significantly slower. 1 Thus separate measurement of the individual stereoisomers would probably not have yielded results different from those we observed in their mixture.
Our estimates of the rates of degradation of atracurium or cisatracurium confirm the apparently diverging results reported previously. In Tris buffer 50 mmol litre found a half-life of atracurium of 58 min in Sørensen buffer at pH:7.3, whereas in our experiments in Sørensen buffer (incubating solution E) the degradation half-life of atracurium was 22 min and that of cisatracuriun 25 min. As the exact composition of the buffer used by Stiller, Cook and Chakravorti 4 was not reported, the longer half-life observed in their studies may be explained by differences in the buffer composition and a lower pH value.
Welch and colleagues 2 reported a half-life for cisatracurium of 34 min in sodium phosphate buffer 67 mmol litre 91 supplemented with, sodium chloride The finding that sodium and potassium ions or glucose influence the elimination reaction of atracurium was surprising, and we cannot offer a satisfactory explanation. An increase in osmolality per se should result in an opposite effect (comparable with the addition of glucose, incubation solution D).
The proposed model for the degradation of atracurium and the generation of laudanosine adequately explained the results under all incubating conditions. The first rate constant characterizing the degradation of atracurium or cisatracurium (k 1 ) was calculated from the degradation rates of the parent drug. We consider the rate constant k 1 a reliable estimate for the generation of the first molecule of laudanosine. As the measured concentrations of laudanosine represented the total concentrations of laudanosine, generation of the second laudanosine molecule was derived as the difference between the measured concentration and estimated concentration of the first laudanosine molecule. Estimate of the second rate constant, k 2 must be considered an approximation. Therefore, comparison of the two rate constants is not justified and no statement can be made as to whether or not the two molecules of laudanosine are formed at similar or different rates. We see the importance of reporting the rate constant k 2 not in its absolute value but in confirming the working hypothesis that the decay of atracurium and cisatracurium conforms with the proposed degradation pathway ( fig. 1 ) with each molecule of the parent compound producing two molecules of laudanosine. In turn, confirmation of this pathway implies that hydrolysis of the parent compounds probably did not occur during the incubations.
The most striking results of our study was the different degradation rate of atracurium in three buffers of identical pH and concentration (pH 7.4, 50 mmol litre
, incubating solutions A, G and H). The results either argue for an influence of the nature of the buffer base itself on the elimination reaction or of the different concentrations of base in the buffer. As Hofmann elimination is a base-catalysed reaction, 5 it depends on the concentration of all of the bases. By definition, pH provides information only on the concentration (activity) of the hydroxide anion but not on the concentration of other bases.
In a buffered solution the concentration of the base is determined by the equilibrium dissociation constant of the buffer pair (pK), concentration (activity) of the hydrogen ions (pH), temperature and total buffer concentration. The theoretically derived curve for different buffers in concentrations of 50 mmol litre 91 at pH 7.4 is represented by the continuous line in the upper panel of figure 3 . The concentration of the base in each of three buffers used in our experiments is indicated (pK values are those for 25ЊC). It is evident that the concentration of the base decreases with higher pK values. Using these data, we plotted the degradation half-lives of atracurium against the estimated concentration of the base for each buffer (lower panel in fig. 3 ). Clearly, degradation of atracurium is enhanced by the increase in base concentration. The conclusion is strengthened further by our observation that degradation is faster in the solutions of a higher total concentration of the Tris (incubation solution H and I) and the sodium phosphate (incubation solution F and B) buffers. The influence of different total concentrations of the same buffer is, however, not as pronounced as that of different buffer bases at identical concentrations.
Some investigators [1] [2] [3] [4] reported faster decay of atracurium in plasma than in a solution buffered to pH 7.4. The observation was explained by postulating ester hydrolysis as an additional degradation pathway. In view of our results, the interpretation needs to be re-evaluated as the rate of degradation in the buffered solution depends on the type and concentration of the buffer. As documented in table 2, the rate of degradation may be much faster or appreciably slower than that in plasma ( 1
2
T approximately 22 min).
Understanding Hofmann elimination of atracurium or cisatracurium as a base-catalysed reaction implies that the degradation rates measured in vitro may not be representative of the rates in vivo. No incubation solution, including plasma, may correctly represent the actual situation in vivo, as (i) plasma contains a variety of different bases in unknown concentrations, (ii) in circulating blood, drugs come into contact with red blood cells and the intima of the blood vessels with unknown concentrations of bases and ions, and (iii) the distribution of atracurium or cisatracurium in the extracellular space exposes the drugs to the bases lining the outer surface of cells. We suggest that the assumption common to all pharmacokinetic models of atracurium, 6 10 or cisatracurium, 7 namely that degradation proceeds at the same rate everywhere in the body and is equal to that measured in vitro, needs to be re-evaluated.
